No abstract available
MeSH terms
-
Antiparkinson Agents / therapeutic use
-
Corpus Striatum / diagnostic imaging
-
Corpus Striatum / metabolism
-
Corpus Striatum / physiopathology
-
Diagnosis, Differential
-
Diagnostic Errors / prevention & control
-
Disease Progression
-
Dopamine / metabolism
-
Dystonic Disorders / diagnosis*
-
Dystonic Disorders / drug therapy
-
Dystonic Disorders / physiopathology*
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Parkinsonian Disorders / diagnosis*
-
Parkinsonian Disorders / physiopathology*
-
Positron-Emission Tomography
-
Substantia Nigra / drug effects
-
Substantia Nigra / metabolism
-
Substantia Nigra / physiopathology
-
Time Factors
-
Treatment Failure
-
Tremor / drug therapy
-
Tremor / etiology*
-
Tremor / physiopathology*
Substances
-
Antiparkinson Agents
-
Dopamine